<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0580">
 <label>116</label>
 <element-citation publication-type="journal" id="rf0570">
  <person-group person-group-type="author">
   <name>
    <surname>Favalli</surname>
    <given-names>E.G.</given-names>
   </name>
   <name>
    <surname>Raimondo</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Becciolini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Crotti</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Biggioggero</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Caporali</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives</article-title>
  <source>Autoimmun Rev</source>
  <volume>16</volume>
  <year>2017</year>
  <fpage>1185</fpage>
  <lpage>1195</lpage>
  <pub-id pub-id-type="doi">10.1016/j.autrev.2017.10.002</pub-id>
  <pub-id pub-id-type="pmid">29037899</pub-id>
 </element-citation>
</ref>
